Back to Search Start Over

Viable virus shedding during SARS-CoV-2 reinfection.

Authors :
Letizia AG
Smith DR
Ge Y
Ramos I
Sealfon RSG
Goforth C
Gonzalez-Reiche AS
Vangeti S
Weir DL
Alshammary H
Chen HW
George MC
Soares-Schanoski A
Lizewski RA
Lizewski SE
Marayag J
Miller CM
Nunez E
Porter CK
Ana ES
Schilling M
Sugiharto VA
Sun P
Termini M
van de Guchte A
Troyanskaya OG
van Bakel H
Sealfon SC
Source :
The Lancet. Respiratory medicine [Lancet Respir Med] 2021 Jul; Vol. 9 (7), pp. e56-e57. Date of Electronic Publication: 2021 May 05.
Publication Year :
2021

Abstract

Competing Interests: All authors declare no competing interests. This study was supported by the Defense Health Agency and Defense Advanced Research Projects Agency. AGL, DRS, CG, DLW, HWC, RAL, SEL, JM, EN, CKP, ESA, MS, VAS, PS, and MT are military service members or government service employees. This work was prepared as part of their official duties. Title 17, US Code §105 provides that copyright protection under this title is not available for any work of the US Government. Title 17, US code §101 defines a US Government work as a work prepared by a military service member or employee of the US Government as part of that person's official duties. The views expressed in the article are those of the authors and do not necessarily express the official policy and position of the US Navy, the Department of Defense, the US Government, or the institutions affiliated with the authors.

Details

Language :
English
ISSN :
2213-2619
Volume :
9
Issue :
7
Database :
MEDLINE
Journal :
The Lancet. Respiratory medicine
Publication Type :
Editorial & Opinion
Accession number :
33964243
Full Text :
https://doi.org/10.1016/S2213-2600(21)00219-8